Newsletter | December 18, 2025
TOP 10 FROM THE EDITOR
1.
Navigating The Complexities Of NK Cell Therapy Development
2.
Navigating Regulatory Complexity In Cell And Gene Therapy
3.
Accelerating NAMs For A Human-Based Future In CGT Development
4.
Navigating CGT Biotech's Financial Headwinds And The Path Forward
5.
The Future of Cancer Immunotherapy Through Allogeneic NK Cell Innovation
6.
Precigen Secures FDA Approval For PAPZIMEOS And Redefines RRP Treatment
7.
Driving Prostate Cancer Innovation Through Immunotherapy With OS Therapies' Dr. Robert Petit
8.
Advancing Telomere Targeting Therapy For Non-Small Cell Lung Cancer
9.
Emerging Technologies For Cell Therapy Manufacturing
10.
How Cynata Therapeutics is Unlocking the Power of iPSCs to Transform Regenerative Medicine
TOP 10 GUEST COLUMNS
Inside Arbor Biotech's In Vivo Gene Therapy Approach
A conversation with Devyn Smith, Ph.D., and Pam Stetkiewicz, Ph.D. — Arbor Biotechnologies
NanoCell's Moonshot Aims To Unlock In Vivo Cell Therapy
A conversation with Maurits Geerlings, M.D., and Jacek Lubelski, Ph.D. — NanoCell Therapeutics
Advancing CAR T Cell Therapy With Logic Gate Engineering
By Francisco Conesa Buendía
Lilly's Exploring A Universal AAV Purification Method
A conversation with Juan-Carlos Rosario, Eli Lilly and Company
Optimizing Lentiviral Vectors For Allogeneic CAR-T Manufacturing
By Emmanuel Mensah, Keck Graduate Institute
Developing Interleukin-2 For Cell Therapies: Key Considerations
By Carlos Bañado, CEO, ARScience Bio
CRISPR And iPSC Disease Modeling And Drug Screening
By Jack (Jie) Huang, M.D., Ph.D.
Exploring The Market For Closed-Loop Cell Therapy Production
By Shubhranshu Gupta, Ph.D., cell therapy expert
From Discovery To Delivery: Accelerating The Path Forward For Gene Therapies
A conversation with Manny Otero, Ph.D., and Sandi See Tai, MD, Lexeo Therapeutics
Manufacturing Interleukin-2 For In Vivo Use: Key Considerations
TOP 10 INDUSTRY INSIGHTS
Non-Viral Vectors In Gene Therapy: LNPs In The Spotlight
By Single Use Support
Navigating The Challenges Of Bringing Cell And Gene Therapies To Market
By Terumo BCT
4 Considerations For Overcoming Challenges In Gene Therapy Testing
By Sarah Sheridan, MilliporeSigma
Overview Of Diffuse Large B-cell Lymphoma: Global Clinical Trial Landscape
By Novotech
The Next Frontier: Industrializing Cell Therapy Manufacturing
Q&A with Cell Process Development Manager, Sara Morlacchi, AGC Biologics
De-Risking Cell Therapy Development: 4 Keys To A Streamlined IND Path
By Dr. Bruce Thompson, Kincell Bio
Insights From The FDA's New FAQ
By Cencora
Understanding Potency In Gene Therapy Development
By Chelsea Pratt, Ph.D., Bio-Rad Laboratories, Inc.
What's Next For Cell And Gene Therapies: Addressing Key Challenges
By InspiroGene
The Basics Of Cell Culture: Key Steps In Manufacturing Cell Therapies
By 3P innovation
TOP 10 SOLUTIONS
A Platform For Continuous Glucose And Lactate Control
Repligen – PAT
Capabilities Update April 2025: Cell & Gene Therapy
SK pharmteco
Cell & Gene Therapy Solutions
Cencora
A Benchtop System For Lipid Nanoparticle (LNP) Formulation
KNAUER
Sterile Cleaning Swabs
Contec, Inc.
Our Approach: Viral Vectors Made Accessible
VintaBio
Roadmap To Successful Drug Therapy Partnerships
Eurofins
Capabilities Update July 2025: Cell & Gene Therapy
Minaris Advanced Therapies
The Future Of Cell & Gene
AGC Biologics
Bridging The Gap Between CGT Innovation And Reality
InspiroGene
